Market Research Industry Reports

Novartis Pharmaceuticals Corp - Pharmaceuticals and Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Novartis Pharmaceuticals Corp (Novartis), a subsidiary of Novartis AG, is a manufacturer of prescription drugs. The company portfolio includes cardio metabolic, ophthalmology, respiratory, neuroscience, immunology and dermatology, oncology, call and gene therapy. It provides medicines such as terbinafine hydrochloride, ceritinib, dabrafenib, nilotinib, rivastigmine tartrate, panobinostat, fingolimod, topotecan, fluvastatin sodium, amlodipine besylate and benazepril hydrochloride, midostaurin, valsartan and hydrochlorothiazide USP and methylphenidate hydrochloride, among others. Novartis markets products in subcutaneous injections, oral granules, soft gelatin capsules, and chewable tablets and suspensions forms. The company offers health education, patient assistance services, healthcare solutions, drug discoveries research and development services. Novartis is headquartered in East Hanover, New Jersey, the US.

Novartis Pharmaceuticals Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Novartis Pharmaceuticals Corp, Medical Devices Deals, 2012 to YTD 2018 9
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Novartis Pharma Acquires Immunotherapy Manufacturing Facility From Dendreon For US$43 Million 11
Partnerships 12
Cure Forward Partners with Novartis Pharma 12
Novartis Pharma Enters into Agreement with Eisai 13
Radius Health Partners with Novartis Pharma for RAD1901 14
Licensing Agreements 15
Intec Pharma Enters into Agreement with Novartis Pharma 15
Equity Offering 16
Altimmune Raises USD14.7 Million in Private Placement of Series B Preferred Shares 16
Asset Transactions 18
Validus Pharma And Wood Creek Capital Management Acquire Six Product Lines From Novartis Pharma 18
Acquisition 20
Novartis Pharma Acquires Selexys Pharma for up to USD665 Million 20
Novartis Pharmaceuticals Corp - Key Competitors 22
Novartis Pharmaceuticals Corp - Key Employees 23
Novartis Pharmaceuticals Corp - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 24
Recent Developments 25
Product News 25
Jul 06, 2018: Novartis and Sandoz withdraw medicines from US over packaging concerns 25
Jul 06, 2018: Sandoz and its affiliate, Novartis Pharmaceuticals voluntarily recall select blister packages of products in the U.S. due to packaging requirements for child resistance 26
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List Of Tables


Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Key Facts 2
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Novartis Pharmaceuticals Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Novartis Pharmaceuticals Corp, Medical Devices Deals, 2012 to YTD 2018 9
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Novartis Pharma Acquires Immunotherapy Manufacturing Facility From Dendreon For US$43 Million 11
Cure Forward Partners with Novartis Pharma 12
Novartis Pharma Enters into Agreement with Eisai 13
Radius Health Partners with Novartis Pharma for RAD1901 14
Intec Pharma Enters into Agreement with Novartis Pharma 15
Altimmune Raises USD14.7 Million in Private Placement of Series B Preferred Shares 16
Validus Pharma And Wood Creek Capital Management Acquire Six Product Lines From Novartis Pharma 18
Novartis Pharma Acquires Selexys Pharma for up to USD665 Million 20
Novartis Pharmaceuticals Corp, Key Competitors 22
Novartis Pharmaceuticals Corp, Key Employees 23
Novartis Pharmaceuticals Corp, Joint Venture 24

List Of Figures


Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Novartis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Novartis Pharmaceuticals Corp, Medical Devices Deals, 2012 to YTD 2018 9

Novartis Pharmaceuticals Corp - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Novartis Pharmaceuticals Corp (Novartis), a subsidiary of Novartis AG, is a manufacturer of prescription drugs. The company portfolio includes cardio metabolic, ophthalmology, respiratory, neuroscience, immunology and dermatology, oncology, call and

USD 250View Report

Novartis AG (NOVN) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products. It provides drugs for

USD 250View Report

Adamis Pharmaceuticals Corp (ADMP) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a biopharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe

USD 250View Report

Acerus Pharmaceuticals Corp (ASP) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Acerus Pharmaceuticals Corp (Acerus), formerly Trimel Pharmaceuticals Corporation develops, manufactures, markets and distributes novel innovative branded products. It focuses on providing mens and womens health. The company uses its proprietary

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Sep 2018
No. of Pages :28
Country :United States of America
Category :Company Profiles
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube